BCG vaccine (Anhui Zhifei Longcom Biologic)

卡介苗（安徽智飞龙科马）

Report date: 2025/01/20 11:10:33

Base Information

Drug NameBCG vaccine (Anhui Zhifei Longcom Biologic)
Drug Alias Name卡介苗（安徽智飞龙科马）
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsUrinary Bladder NeoplasmsPapillomaTuberculosis, Pulmonary +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesAnhui Zhifei Longcom Biopharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAnhui Zhifei Longcom Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsUrinary Bladder NeoplasmsPapillomaTuberculosis, Pulmonary +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A